Literature DB >> 27070231

Comparison of Dysfunctional Lens Index and Scheimpflug Lens Densitometry in the Evaluation of Age-Related Nuclear Cataracts.

Fernando Faria-Correia, Isaac Ramos, Bernardo Lopes, Tiago Monteiro, Nuno Franqueira, Renato Ambrósio.   

Abstract

PURPOSE: To describe the Dysfunctional Lens Index (DLI) from ray-tracing aberrometry and to test its correlations with logMAR corrected distance visual acuity (CDVA) and lens grading based on the Lens Opacities Classification System III (LOCS III) and the Scheimpflug-based lens density.
METHODS: The DLI was calculated by the i-Trace Visual Functional Analyzer (Tracey Technologies, Houston, TX). Forty eyes of 30 patients with mild to moderate age-related nuclear cataract were included retrospectively. Nuclear opalescence grading was obtained by slit lamp using the LOCS III, and objective lens densitometry was evaluated by Scheimpflug imaging (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany). The average density parameter obtained by Scheimpflug imaging of the nucleus lens was considered.
RESULTS: The DLI showed a high negative linear correlation with the LOCS III nuclear opalescence score (r = -0.662; P < .01). The average density of the lens nucleus was positively correlated with the LOCS III nuclear opalescence score (r = 0.682; P < .01). The CDVA had a stronger relationship with the DLI parameter (r = -0.702, P < .01) compared to the average density values (r = 0.630, P < .01).
CONCLUSIONS: The DLI was correlated with the LOCS III nuclear opalescence score and the Scheimpflug-based lens density. The DLI had a stronger correlation with CDVA compared to the LOCS III classification or the Scheimpflug-based lens density. The DLI may improve the preoperative evaluation of nuclear cataract and the monitoring of its progression. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27070231     DOI: 10.3928/1081597X-20160209-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  8 in total

1.  Effect of aberrometry in diagnosis of isolated spherophakia.

Authors:  Zhe Zhang; Su-Hua Zhang
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

2.  Long-term development of lens fluorescence in a twin cohort: Heritability and effects of age and lifestyle.

Authors:  Jakob Bjerager; Sami Dabbah; Mohamed Belmouhand; Line Kessel; Jesper Leth Hougaard; Simon P Rothenbuehler; Birgit Sander; Michael Larsen
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Characterization of Dysfunctional Lens Index and Opacity Grade in a Healthy Population.

Authors:  Elena Martínez-Plaza; Pedro Ruiz-Fortes; Roberto Soto-Negro; Carlos J Hernández-Rodríguez; Ainhoa Molina-Martín; Alfonso Arias-Puente; David P Piñero
Journal:  Diagnostics (Basel)       Date:  2022-05-07

4.  Observational Clinical Studies of Human Lens Transparency Using the Vision Index Pen.

Authors:  Azin Abazari; Harbans S Dhadwal; John Wittpenn
Journal:  Transl Vis Sci Technol       Date:  2019-11-15       Impact factor: 3.283

Review 5.  From Presbyopia to Cataracts: A Critical Review on Dysfunctional Lens Syndrome.

Authors:  Joaquín Fernández; Manuel Rodríguez-Vallejo; Javier Martínez; Ana Tauste; David P Piñero
Journal:  J Ophthalmol       Date:  2018-06-27       Impact factor: 1.909

6.  Correlation and predictability of ocular aberrations and the visual outcome after quadrifocal intraocular lens implantation: a retrospective longitudinal study.

Authors:  Chia-Yi Lee; Jing-Yang Huang; Chi-Chin Sun; Shun-Fa Yang; Hung-Chi Chen; Hung-Yu Lin
Journal:  BMC Ophthalmol       Date:  2019-08-19       Impact factor: 2.209

7.  Multimodal imaging for refractive surgery: Quo vadis?

Authors:  Renato Ambrósio
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

8.  Using Optical Quality Analysis System for predicting surgical parameters in age-related cataract patients.

Authors:  Thibaud Garcin; Damien Grivet; Gilles Thuret; Philippe Gain
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.